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Background and purpose — An enhanced treatment program 
may decrease 30-day mortality below 20% after lower extrem-
ity amputations (LEA). The potential and limitations for fur-
ther reduction are unknown. We analyzed postoperative causes 
of 30-day mortality, and assessed failure to rescue (FTR) rate in 
LEA patients who followed an enhanced treatment program.
Patients and methods — Medical charts of 195 primary LEA 
procedures were reviewed independently by 3 of the authors, and 
deaths during hospitalization following amputation were classi-
fi ed according to consensus. 
Results — 31 patients died within 30 days after surgery. 4 
deaths were classifi ed as “defi nitely unavoidable,” 4 as “probably 
unavoidable,” and 23 as “FTR.” Patients who died had a higher 
incidence of sepsis, pneumonia, and acute myocardial infarction 
compared with those alive. A log binominal regression analysis 
adjusted for age, sex, ASA score, diabetes, nursing home admis-
sion, transfemoral amputation (TFA), and BMI showed that the 
risk of 30-day mortality was increased for TFA (RR = 2.3, 95% CI 
1.1–4.8) and for patients with diabetes (RR = 2.7, 95% CI 1.3–5.6). 
The FTR rate (patients with 30-day mortality/all patients with a 
severe postoperative complication) was 30%. Of the FTR deaths, 
20 at some point had active lifesaving care curtailed. 
Interpretation — Future initiatives should be directed at 
enhanced sepsis and pneumonia prophylactic actions, in addition 
to close monitoring of hemodynamics in anemic patients, with the 
potential to further reduce morbidity and mortality rates. 
■
30-day mortality rates in excess of 30% have been reported 
in patients following a major dysvascular lower extremity 
amputation (LEA) (Kristensen et al. 2012). Beyond athero-
sclerosis or diabetes, treatment is most often challenged by 
several competing co-morbidities and high age (Kristensen et 
al. 2012, Wied et al. 2016). Perioperative optimization may 
reduce morbidity and mortality. Thus a recent study reported 
decreased mortality rates following an enhanced in-hospital 
treatment program (Kristensen et al. 2016), but the potential 
and limitations of a further reduction in mortality are unknown. 
The mortality rates are frequently used to compare the quality 
of treatment between hospitals. However, this has recently 
been challenged since some deaths in hospital are inevitable. 
As stated by Silber et al. (1992, 2007), the mortality is related 
to the degree of illness and co-morbidity of patients receiving 
treatment and not necessarily the expression of differences in 
the quality of care. Failure to rescue (FTR)—the probability of 
death if experiencing a severe postoperative complication—is 
becoming increasingly popular as an indicator showing how 
well hospitals perform once the complications occur (Silber 
et al. 1992, 2007). 
The aim of this study is to analyze causes of 30-day mortal-
ity after LEA procedures and the FTR rate. We hypothesize 
that some of the 30-day deaths could be classifi ed as FTR 
cases. 
Patients and methods 
Hvidovre University Hospital Copenhagen has a catchment 
area of around 600,000 people, and performs all non-trau-
matic amputations in the area resulting in approximately 100 
major dysvascular LEAs per year. The study is a single-center 
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retrospective cohort study of patients with a primary LEA 
admitted between January 2013 and April 2015. All patients 
with primary LEA were assessed for inclusion if the limb was 
amputated because of arteriosclerosis or diabetic complica-
tions. Exclusion criteria were bilateral amputation procedures 
and re-amputations. 
All LEA patients follow a well-defi ned enhanced rehabilita-
tion program, in an acute orthopedic ward (Kristensen et al. 
2016). 
Preoperative management
Patients referred from general practitioners, outpatient clin-
ics, or emergency departments have their ankle-brachial blood 
pressure index measured, and their medical record is submit-
ted to the vascular surgeons for the possibility for revascu-
larization. If revascularization is deemed unobtainable by the 
Department of Vascular Surgery a supplementary measure-
ment of skin perfusion pressure is performed to aid the deci-
sion on the amputation level. Senior consultants then review 
the indication for amputation. The patients are treated upon 
arrival at our department according to standardized fl uid and 
transfusion protocols. The patients receive prophylactic anti-
biotics (dicloxacillin intravenously) before surgery and low-
dose low-molecular-weight heparin after surgery.
Intraoperative management
The surgery is performed by trained residents or senior con-
sultants. All transtibial amputations (TTA) procedures are per-
formed approximately 12 cm below the knee joint, with sagit-
tal fl aps ad modum Persson (Persson 1974). The transfemo-
ral amputation (TFA) procedure is performed with standard 
anterior and posterior skin fl aps approximately 10 cm above 
the knee joint. Through-knee exarticulation (TKE) is rarely 
performed. The tissue vitality is assessed regularly during the 
operation, and the patient is informed of the risk of amputation 
at a more proximal level if tissue intraoperatively is deemed 
not to be vital. Spinal or general anesthesia is used during sur-
gery. An ischiatic catheter with a continued infusion of (2 mg/
mL) ropivacaine at a rate of (4 mL/h) with a possible bolus 
of 5 mL and 30 min lockout time is placed during the TFA. A 
peripheral nerve catheter with continuous infusion is applied 
after surgery for TTA to provide extended analgesia for the 
fi rst 4 postoperative days.
Postoperative management
Postoperatively the oral intake of fl uids is supplemented with 
1.000 mL standard rehydration fl uid (isotonic Na-K-glucose 
or Ringer’s lactate) administered intravenously. Fluid balance 
is measured from daily body weight if possible, while hemo-
globin and blood electrolytes and creatinine are measured 
preoperatively and until the fourth postoperative day. Hypo-
volemic patients are rehydrated with fl uid at 20 mL/kg body 
weight. The unit uses a liberal blood transfusion trigger of 6 
mmol/L for the fi rst 4 days postoperatively. 
Patients are mobilized as soon as possible after surgery. 
Physiotherapy is started on postoperative day 1 and continued 
for 2–5 days during weekdays (for most patients, on a daily 
basis) until discharge (Kristensen et al. 2016). 
Data collection and management
3 of the authors reviewed the medical charts independently, 
and deaths within 30 days from amputation or during primary 
hospitalization were classifi ed according to consensus, as: 
“Defi nitely unavoidable” being a result of either pre-ampu-
tation terminal disease or the patient refusing relevant post-
operative care such as nutrition, fl uids, and rehabilitation, or 
“probably unavoidable” being a result of pre-amputation acute 
life-threatening medical illness with predictable short life 
expectancy (< 1 month) (Foss and Kehlet 2005). The remain-
ing deaths classifi ed as FTR were defi ned as those that were 
related to possible avoidable postoperative complications. We 
noted whether the patients who died had a notation in their 
charts on restrictions in the level of active therapy (Foss and 
Kehlet 2005). Also, the triggering complication of death, 
based on the medical chart review, was registered. The FTR 
rate is calculated as patients with 30-day mortality/all patients 
with a severe postoperative complication (Henneman et al. 
2013). The patients classifi ed with “defi nitively” or “prob-
ably” unavoidable deaths were excluded from the FTR cal-
culation. Patients who developed 1 of the following 8 com-
plications while hospitalized were included in the FTR cal-
culation: radiographically verifi ed pneumonia or respiratory 
failure, sepsis, acute renal failure (postoperative creatinine 
> 200 µmol/L), stroke, gastrointestinal complication (ileus, 
hemorrhage), acute myocardial infraction, requirement for 
more than 3 blood transfusions within 72 hours from surgery, 
and re-amputation at a higher level within 30 days from index 
amputation. We were cautious not to register preexisting dis-
eases as postoperative complications. The fi ndings were dou-
ble-checked by 2 independent researchers.
Statistics
Continuous data are presented as median values with inter-
quartile ranges (IQRs) or mean values with standard devia-
tions (SD). Categorical data are presented as numbers and 
were compared using the chi-square test or Fisher’s exact test 
in cases with cell counts of 5 or less. Log binominal regression 
analysis, with 30-day mortality as dependent variable, was 
used to assess the relative risk of variables with known infl u-
ence on 30-day mortality (Barros and Hirakata 2003, Kris-
tensen et al. 2012, Karam et al. 2013). The selected variables 
were: age, sex, ASA score, diabetes, nursing home admission, 
TFA, and BMI. A corresponding model evaluated the 30-day 
mortality of FTR patients with active care curtailed, compared 
with those who survived. Log binominal regression analysis 
was used due to the relatively few events, thereby eliminat-
ing the risk of an overestimation of the estimates from simple 
multivariable logistic regression analysis (Barros and Hirakata 
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2003). To our knowledge our study is the fi rst analyzing mor-
tality causality in this group of patients, which is why we were 
not able to assess variability or distribution before the data 
collection. 
Ethics, funding, and potential confl icts of interest
The study was approved by the local ethics committee and reg-
istered with the regional data protection agency (04.12.2012) 
(j. no. 01975 HVH-2012-053). No benefi ts in any form have 
been received or will be received from any commercial party 
related directly or indirectly to the subject of this article. No 
competing interests were declared.
Results
195 consecutive patients with a single primary major dys-
vascular LEA procedure were included in the study between 
January 2013 and April 2015 (Figure 1 and Table 1). 
Causes of death
31 of the 195 patients died in hospital within 30 days after 
surgery (median of 6 postoperative days (IQR: 4.5–10)): 22 
post-TFA procedures and 9 post-TTA procedures (Table 1 and 
see Supplementary data). There was a statistically signifi cant 
higher incidence of postoperative sepsis, pneumonia, and 
acute myocardial infarction among the patients who died com-
pared with the survivors in univariable analysis. In an adjusted 
log binominal regression analysis TFA and diabetes were 
associated with an increased risk of 30-day mortality (TFA: 
RR = 2.3, CI = 1.1–4.8, p = 0.03 and diabetes: RR = 2.7, CI 
= 1.3–5.6, p = 0.01) (Table 2, see Supplementary data). The 
22 patients who died in the TFA sub-group received statisti-
cally signifi cantly more blood transfusions during the period 
from 2 days before surgery and until the fi fth postoperative 
day [median of 3.0 units vs. 2.0 units (p = 0.02)] compared 
with those 88 patients alive in the TFA group.
Estimation of FTR
4 deaths were classifi ed as “defi nitely unavoidable,” 4 as 
“probably unavoidable,” and 23 as FTR, of which 20 patients 
at some point had active care curtailed (Table 3). 53 patients 
experienced at least 1 of the 8 defi ned complications during 
their stay at the hospital. The FTR rate was 30% (postopera-
tive complications among all 195 patients may be found in 
Table 4, see Supplementary data). 
Discussion
The 16% 30-day mortality rate in this study is comparable with 
previous European studies (Moxey et al. 2010) and it shows 
how severely ill patients are when admitted to the department 
of orthopedic surgery for a dysvascular-related primary LEA. 
84% of the patients had an ASA score of 3–4, most likely the 
highest within the orthopedic specialty. Patients with diabetes 
or patients having TFA surgery performed all had an elevated 
risk of 30-day mortality. 
One-quarter of the deaths were highly expected in patients 
suffering preoperatively from the consequences of septic 
shock, severe sequelae after recent massive stroke, or unre-
coverable respiratory failure. Nevertheless, they had surgery 
scheduled and performed. This is remarkable and leaves an 
impression of how selected patients could have a more digni-
Figure 1. Flow chart of amputee patients at Hvidovre Hospital, from 
January 2013 to April 2015. TTA = transtibial amputation, TKE = 
through knee ex-articulation, TFA = transfemoral amputation.
Table 1. Patient characteristics, n = 195. Values are number of 
patients unless otherwise stated
 
 Survivors Non-survivors
Factor n = 164 n = 31
Male sex   90     19  
Female sex   74     12  
Age in years, mean (SD)   74 (12)   78 (13)
Own home 110    22  
Nursing home   54       9   
Body mass index, mean (SD)   24.6 (6.5)   23.5 (6.8)
New mobility score, mean (SD)      3.9 (2.8) a     2.5 (3.2) b
Diabetes type I or II   68     18 
Dementia   22       2  
ASA score > 2 135    29  
Transtibial amputation   71       9   
Through-knee amputation     5        0   
Transfemoral amputation   88     22 
Intraoperative blood loss (mL), 
 median (IQR) 300 (150–500) 400 (200–675)
General anesthesia   46       9   
a n = 140.
b n = 22.
Amputations assessed for eligibility (n = 243): 
– TTA, 86
– TKE, 5
– TFA, 150
– hip ex-articulation, 2
Excluded (n = 48):
– bilateral amputations, 12
– re-amputations, 36
   (7 of whom died within 30 days 
   of their index amputation)
   re-amputations were conversions 
   from: 
      TTA, 26
      TKE, 4
      TFA, 6
Patients included in the study (n = 195)
31 patients with 30-day perioperative death
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fi ed death than is the case today if more attention were paid 
to the possibility of non-surgical palliative treatment. Thus, 
for some patients, limb ischemia/severe infections along with 
serious co-morbidities are part of the death process, and a non-
surgical approach might be more ethically correct. However, 
we acknowledge that an algorithm on how to select patients 
for non-surgical palliative treatment is diffi cult. 
If the mortality rate from postoperative acute myocardial 
infraction is to be reduced, it seems critical that hypoperfu-
sion is avoided (Dhalla et al. 2010). Clinical estimation alone 
to guide blood transfusion is probably inadequate (Ram et al. 
2014). Daily Hgb measurement is to be recommended, and a 
close regulation of LEA patients’ hemodynamics before and 
after surgery is important. 
Even with a perioperative standard for fl uid therapy and 
antibiotic during surgery, sepsis and pneumonia remain sig-
nifi cant challenges. It seems reasonable to consider extending 
antibiotic prophylaxis into the early postoperative days. Issues 
such as tissue hypoxia due to surgical stress could be insuf-
fi ciently monitored on regular wards by blood pressure, heart 
rate, and saturation only. Different invasive and non-invasive 
techniques provide an enhanced assessment of optimal oxygen 
delivery, and individualized goal-directed hemodynamic ther-
apy (Sobol and Wunsch 2011) is perhaps something that needs 
to be included more often in LEA surgery in the future. 
Since our study, to our knowledge, is the fi rst to apply the 
FTR approach in LEA surgery, it is compared with hip frac-
ture patients with similar demographics. Our patients had 
an exceptionally high FTR rate. Thus, a US register study 
on patients with hip fracture published in 2015 with a large 
patient population reported an FTR rate of 6% (Menendez and 
Ring 2015). The difference may be explained by different co-
morbidity patterns. 
The fact that 20 of the 23 patients classifi ed as FTR deaths 
received less than maximum postoperative care gives cause 
for concern. Doctors curtailed active care on ethical grounds 
considering the current health status, mental status, and the 
pre-amputation function level. The decision to curtail active 
care was taken by the attending medical staff, and not infl u-
enced by the authors of this study. Going through the medical 
records it became evident how the decision not to refer to ICU 
or active revival was settled. Frequently it was through a con-
versation between the attending resident and a consultant in 
the situation of a quickly deteriorating patient. This is stressful 
and not the ideal time for such discussions. 
There are several limitations to this study. The percentage of 
patients classifi ed as FTR could be too high, and the investi-
gators could have overlooked some complications among the 
survivors. This could infl uence the FTR rate and to some extent 
explain the exceptionally high percentage. The usage of FTR 
is relatively new and what diagnoses should be included in the 
calculation is still being debated. A recent study evaluating the 
concept of FTR found that administrative data are inaccurate 
in the general hospital population and the FTR rate ought not 
to be used in its current state for comparative purposes (Hor-
witz et al. 2007). Another limitation is the retrospective clas-
sifi cation of cause of death. However, the fi nal classifi cation 
was based on the consensus of 3 specialists, including the one 
responsible for the corresponding hip fracture study (Foss and 
Kehlet 2005). The data represent the biggest dataset on the 
subject and provide a background for further exploratory anal-
ysis of the subject. The data are partly qualitative, highlight-
ing the fact that there is both a group where care is probably 
futile as well as a group where postoperative care is probably 
inadequate. Ideally a future study on this question should be 
prospective, with independent assessments preoperatively and 
postoperatively, preferably daily, but at least weekly. From our 
work and analysis process it became clear that future trials 
will gain considerably from the recommendations listed in the 
Appendix.
In summary, the 30-day mortality within this study is com-
parable to previous studies and shows the potential in continu-
ous research in perioperative strategies. Diabetic patients and 
patients with TFA have an elevated risk of 30-day mortality. 
Postoperative sepsis, pneumonia, and acute myocardial infarc-
tion are the main complications leading to death following 
Table 3. Classifi cation of patients according to the potential for avoiding death. Values are 
number of patients unless otherwise stated 
  Defi nitely Probably Failure
  unavoidable unavoidable to rescue Total
Factor n = 4 n = 4 n = 23 n = 31 a
Active care curtailed, no/yes 0/4 1/3 3/20 4/27
Estimated cause of death:
 Stroke 0 1 3 4
 Acute myocardial infarction 0 0 6 6
 Pneumonia or respiratory failure 2 0 5 7
 Sepsis 2 2 4 8
 Renal failure 0 0 3 3
 Gastrointestinal ileus or hemorrhage 0 1 2 3
Postop. days to death, median (IQR) 7 (2.0–9.8) 5 (2.8–6.5) 7 (4.0–11)       6 (4.5–10)
 
a 22 transfemoral and 9 transtibial amputations.
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LEA surgery. It seems apposite to recommend a future inten-
sifi ed focus on the perioperative optimization of LEA patients, 
and with room for improvements. 
Supplementary data
The Appendix and Tables 2 and 4 are available as supplemen-
tary data in the online version of this article, http://dx.doi.org/ 
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